Paloma Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,490
Closed -$305K 2178
2021
Q3
$305K Buy
+3,490
New +$316K 0.01% 711
2021
Q2
Sell
-5,699
Closed -$432K 2399
2021
Q1
$432K Buy
+5,699
New +$430K 0.01% 1223
2020
Q4
Sell
-5,121
Closed -$272K 2371
2020
Q3
$272K Sell
5,121
-118,186
-96% -$7.04M 0.01% 1552
2020
Q2
$7.18M Buy
+123,307
New +$6.63M 0.12% 183
2019
Q4
Sell
-7,688
Closed -$409K 2597
2019
Q3
$409K Buy
+7,688
New +$395K 0.01% 1316
2017
Q4
Sell
-12,387
Closed -$648K 2395
2017
Q3
$648K Sell
12,387
-5,947
-32% -$332K 0.01% 1396
2017
Q2
$1.07M Sell
18,334
-50,640
-73% -$2.63M 0.01% 1159
2017
Q1
$3.16M Buy
68,974
+47,558
+222% +$2.37M 0.04% 519
2016
Q4
$1.13M Buy
21,416
+81
+0.4% +$3.92K 0.01% 1102
2016
Q3
$951K Buy
21,335
+7,235
+51% +$314K 0.01% 1058
2016
Q2
$538K Sell
14,100
-35,514
-72% -$1.56M 0.01% 1502
2016
Q1
$2.04M Buy
49,614
+35,688
+256% +$1.47M 0.03% 477
2015
Q4
$676K Buy
+13,926
New +$619K 0.02% 862

Other funds holding SYNH

Paloma Partners's SYNH Position: Q4 2021 in Review

Paloma Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 3,490 shares — an estimated $305K sold.

Paloma Partners first reported a position in SYNH in Q4 2015 and held it in 13 quarters. The position peaked at $7.18M in Q2 2020. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

  • Paloma Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Paloma Partners sold 3,490 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $305K.
  • Paloma Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 13 quarters.
  • Paloma Partners's Syneos Health, Inc. Class A Common Stock position peaked at $7.18M in Q2 2020.
  • 378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Paloma Partners's 13F filing for Q4 2021, filed 14 Feb 2022.